Categorization and association analysis of risk factors for adverse drug events Lina ZhouAnamika Paul Rupa Review 08 December 2017 Pages: 389 - 404
Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case–control studies of incidence and associated risk factors Nobuaki MoriYoshio KamimuraSeiji Bito Clinical Trial 08 December 2017 Pages: 405 - 411
Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics Kevin J. FreiseBeibei HuAhmed Hamed Salem Clinical Trial 04 January 2018 Pages: 413 - 421
Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China Zhixiong ZhongJingyuan HouPingsen Zhao Pharmacogenetics 14 December 2017 Pages: 423 - 431
Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis Ping WangXiao-Qian LinGong-Hao He Pharmacogenetics 14 December 2017 Pages: 433 - 442
Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel Mirjana NovkovicDragan MaticLjiljana Rakicevic Pharmacogenetics 19 December 2017 Pages: 443 - 451
Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel Mirjana NovkovicDragan MaticLjiljana Rakicevic Correction 05 February 2018 Pages: 453 - 453
In vitro studies and in silico predictions of fluconazole and CYP2C9 genetic polymorphism impact on siponimod metabolism and pharmacokinetics Yi JinHubert BorellGian Camenisch Pharmacogenetics Open access 22 December 2017 Pages: 455 - 464
Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer A. E. C. A. B. WillemsenL. M. KnapenN. P. van Erp Pharmacokinetics and Disposition Open access 08 December 2017 Pages: 465 - 471
Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine Nadège NéantFlorence GattaccecaCaroline Solas Pharmacokinetics and Disposition 26 January 2018 Pages: 473 - 481
Prevalence of pain and pharmacological pain treatment among old people in nursing homes in 2007 and 2013 Eva-Stina HemmingssonMaria GustafssonHugo Lövheim Pharmacoepidemiology and Prescription Open access 20 December 2017 Pages: 483 - 488
Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study Katarina DatheStephanie PadbergChristof Schaefer Pharmacoepidemiology and Prescription 07 December 2017 Pages: 489 - 495
Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports? Kristian SvendsenKjell H. HalvorsenBeate Garcia Pharmacoepidemiology and Prescription 18 December 2017 Pages: 497 - 504
Degree of prescriber’s knowledge about variability in biological drugs “innovators” in manufacturing process Lucía Jiménez-PichardoRocío Gázquez-PérezJesús Francisco Sierra-Sánchez Pharmacoepidemiology and Prescription 15 December 2017 Pages: 505 - 511
The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures R. A. CharltonV. BettoliH. Dolk Pharmacoepidemiology and Prescription 11 December 2017 Pages: 513 - 520
Domperidone prolongs oral to duodenal transit time in video capsule endoscopy Michael McfarlaneB. LiuC. Nwokolo Pharmacoepidemiology and Prescription 08 December 2017 Pages: 521 - 524
Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining Camille MorivalRichard WesterlynckPascal Le Corre Pharmacoepidemiology and Prescription 18 December 2017 Pages: 525 - 534
Drug use in pregnant women—a pilot study of the coherence between reported use of drugs and presence of drugs in plasma Emelie WolgastAnn JosefssonMargareta Reis Pharmacoepidemiology and Prescription Open access 20 December 2017 Pages: 535 - 539